Hvivo Services
Early-phase clinical trials, human challenge studies and lab services for biopharma and biotech sponsors
Highlights
- New on EvolcAdded 2026-10-28
About Hvivo Services
hVIVO is a clinical research organisation that runs Phase I–III clinical trials, human challenge trials, specialist infectious disease and immunology laboratory services, drug development consultancy, clinical trial recruitment, and biological sample storage. Its services are integrated and can be used end to end or as targeted support.
Its clients are global biopharma companies, emerging biotechs, pharmaceutical companies and CROs, which commission its clinical, laboratory, consultancy and recruitment services for individual programmes. The company operates a network of five clinical sites in the UK and Germany, and its recruitment teams in Germany and the UK provide access to healthy volunteers and patient populations.
The group was founded in 1988 and is headquartered in London. Its laboratories are located in Canary Wharf and Greenwich, London. The group includes Cryostore, CRS and Venn Life Sciences, which now operate under the single hVIVO brand; CRS was acquired in January 2025. The company also lists offices and medical teams in Paris, Kiel and Mannheim.
Product: Integrated early-phase clinical development services: Phase I–III trial delivery, human challenge trials, lab services, consultancy, recruitment and sample storage.
Jobs at Hvivo Services
Leadership
- John Oxford · Our founderSource: company website
- Richard Cotton · Interim Chief Financial Officer (CFO)Source: company website
- Isabelle Ackermann · Head of Data ManagementSource: company website
More biotech & pharma companies
Hyfacol
Medical-grade collagen manufacturing platform for advanced wound care and guided bone regeneration productsYoung companyNew on EvolcHypha Discovery
Specialist CRO making drug and agrochemical metabolites, purifying compounds and running MetID studies for pharma clientsNew on EvolcIlc Therapeutics
Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSVNew on EvolcImaging Endpoints
Oncology imaging CRO that designs, reads and analyses imaging endpoints for pharma sponsors' clinical trialsNew on Evolcimmunesystems.co.uk
UK supplier of antibodies, ELISA kits, labeling kits and lab reagents for life sciences researchers and producersNew on EvolcImmunocore
Biotech developing ImmTAX-based T cell receptor therapies for cancer, infectious and autoimmune diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Analytics 4
- Google Tag Manager
- HubSpot
- HubSpot CMS